The ethics of expanding access to cheaper, less effective treatments

The Lancet:S0140-6736(15)01025-9 (2016)
Download Edit this record How to cite View on PhilPapers
This article examines a fundamental question of justice in global health. Is it ethically preferable to provide a larger number of people with cheaper treatments that are less effective (or more toxic), or to restrict treatments to a smaller group to provide a more expensive but more effective or less toxic alternative? We argue that choosing to provide less effective or more toxic interventions to a larger number of people is favored by the principles of utility, equality, and priority for those worst-off. Advocates are mistaken to demand that medical care provided in low-income and middle-income countries should be the same as in high-income countries.
PhilPapers/Archive ID
Revision history
Archival date: 2016-08-27
View upload history
References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Added to PP index

Total views
103 ( #23,506 of 39,912 )

Recent downloads (6 months)
42 ( #12,092 of 39,912 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks to external links.